Back to search

National and Kapodistrian University of Athens

Μελέτη της δράσης αδρενεργικών και χολινεργικών παραγόντων (αγωνιστών - ανταγωνιστών) σε λευχαιμικά κύτταρα. Δοκιμασίες In vitro σε υγρές καλλιέργειες

Abstract

dc:description

Based on the evident knowledge of autonomic innervation of the bone marrow, as well as the functional interaction between the immunological and autonomic nervous system, the aim of this study is to clarify the effect of neuropeptides and specifically to investigate the role of adrenergic and cholinergic factors (agonists, antagonists) on leukaemic cells. The material of the study consists of cells derived from 4 established leukaemic cell lines (aged 5-11 years) and blastic cells from the peripheral blood of patients with acute leukaemia (8 with AML and 3 with ALL). • Cell lines: Cell lines KG-91 [derived from AML-M3 t(15;17)] and KA-93 [from HCLv 14q+] express only erythroid markers (GlycA and γ-chains). The remaining two cell lines, ZA-93 [derived from AML-M1 t(8;21)] and MK-97 [from AML-M4Eο inv16] are EBV(+), express B lymphoid markers and excrete MIP1a, but differ regarding immunoglobulin expression (ZA-93: IgMK, MK-97: IgAK). • Acute leukaemia blast cells: AML (2 Ml, 2 M2, 2 M3v, 2 M4), ALL (1 B, 2 T). • Adrenergic factors: Methoxamine (α1-agonist), clonidine (α2-agonist), phentolamine (α-antagonist), isoproterenol (β-agonist), propranolol (β-antagonist), butoxamine (β2-antagonist), epinephrine (mixed α and β agonist). • Cholinergic factors: carbamylcholine (carbachol - agonist), atropine (antagonist). The liquid cellular cultures used, had a duration of 1-4 or occasionally more days. Cells with viability >80% and initial concentration of 0,1-0,5 X 106/ml were suspended in the medium (RPMI 1640 - Glutamax I with FBS 15%), with and without ("control cells") the addition of neuropeptide in final concentration of 1aM - 1mM, and were placed in the incubator. In regular intervals, samples were retrieved from the medium for cell counting, assessment of cell viability and cellular preparations in order to check their phenotype (immunophonotype with APAAP) and to detect apoptosis (in situ TUNEL-test). The results have shown that adrenergic factors exercise certain effects on the leukaemic cells, namely: A. Adrenergic factors. • α-Adrenergic factors: The agonists methoxamine and clonidine were tested in all 4 cell lines and were found to exercise statistically significant cytostatic effect at concentrations of 1mM (and occasionally 100μΜ). The inhibition of cell growth is obvious from the 2nd day. No apparent effects on the viability of the cells or apoptosis were observed. All cells retained their morphology. Immunophenotypically the expression of the erythroid markers GlycA and γ-chains was reduced in KG-91 and KA-93 cells. In ZA- 93 cells the expression of MIP1a and sΙgMΚ was significantly increased, while the relevant markers in MK-97 cells remained unchanged. The antagonist phentolamine exhibited also a cytostatic effect in KG-91 cells, but not in KA-93. The findings are in line with the results from published studies on normal precursor cells. • β-adrenergic factors: Cells from all 4 lines exhibited statistically significant inhibition of their growth after the 2nd day, in the presence of isoproterenol at concentration of 100μΜ and in some cases 10μΜ. Occasionally this is combined with reduction of their viability and rarely with apoptosis. Phenotypically, a small decrease in the expression of the erythroid markers in KG-91 and KA-93 cells, as well as B lymphoid markers in ZA-93 and MK-97 was observed. A significant reduction was noted in the secretion of MIP1a by cells of the ZA-93 line within 24h, at low concentrations of isoproterenol (100nΜ-10μΜ), where no changes of their growth or viability were observed. On the other hand, isoproterenol at the same concentration and for the same time period did not affect MK- 97 cells. Similar results, showing decrease in cell growth, were also observed on blast cells derived from 4 AMLs (1 M1, 2 M3v and 1 M4). The effects of isoproterenol described can be explained by its ß-adrenergic agonist action, resulting in an increase in intracellular cAMP, which arrests cell growth in G1 or G0/G1 phase of the cell cycle, and even leads in apoptosis. Concerning β-adrenergic antagonists, the effect of propranolol is similar to the action of agonists, inhibiting cell growth in KG-91 and KA-93 cell lines. In contrast, butoxamine has no effect on the above cells. • Mixed α and β agonists: Epinephrine, at concentrations of 100μΜ (or even 10μΜ in some cases) leads to decrease of cell growth and viability and induces apoptosis in all cell lines from the 1st day. ZA-93 cells exposed to small concentrations of epinephrine (100nM- 10μΜ) for 24h, exhibited decreased secretion of MIP1a (proportional to the one caused by isoproterenol), while their growth rate remained unchanged. On the other hand, for the same concentration of epinephrine, MK-97 cells exhibited a reduction in growth rate and viability, combined with apoptosis, but not with true decrease of MIP1a secretion. In blast cells of acute leukaemias, epinephrine, at the same concentrations (10-100pM), results in reduction of cell viability and expression of specific markers, as well as apoptosis in certain degree. The augmented cytostatic and apoptotic effects of epinephrine may be due to its combined α and β adrenergic agonist action. In conclusion, the effects of adrenergic agonists on the growth and the phenotype of leukaemic cells point out to a direct, non-toxic action, possibly via adrenergic receptors. Specifically, as far as cell growth is concerned: i. α-adrenergic factors exhibit a cytostatic effect, ii. β-adrenergic factors also exhibit cytostatic and potentially apoptotic action, and iii. mixed adrenergic factors act mainly by inducing cellular apoptosis. Differences concerning the susceptibility and responsiveness of leukaemic cell lines to adrenergic factors, especially those sharing the same phenotype, are obviously related to the different origin and nature of the cells. Similarly, the differences noted on blast cells of acute leukaemias should be attributed to their heterogeneity, and in some degree to the purity of the blast population. B. Cholinergic factors. In contrast to adrenergic, cholinergic factors at concentrations 1aM-1mM that have been tested on the cells of the 4 cell lines had no effect on the growth or phenotype of the cells. Although the results of the present study offer certain suggestions for the functional role of the factors studied, further scientific research is required.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2002

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Τασιόπουλος, Στέργιος
  • Tassiopoulos, Stergios

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/20059

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Τασιόπουλος, Στέργιος; Tassiopoulos, Stergios. Μελέτη της δράσης αδρενεργικών και χολινεργικών παραγόντων (αγωνιστών - ανταγωνιστών) σε λευχαιμικά κύτταρα. Δοκιμασίες In vitro σε υγρές καλλιέργειες. National and Kapodistrian University of Athens, 2002. http://hdl.handle.net/10442/hedi/20059